Free Trial

Haemonetics (HAE) SEC Filings & 10K Form

$90.58
+1.08 (+1.21%)
(As of 07/12/2024 ET)

Recent Haemonetics SEC Filings

DateFilerForm TypeView
07/12/2024
3:25 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
3:42 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
5:30 AM
Haemonetics (Filer)
Form DEFA14A
06/07/2024
5:31 AM
Haemonetics (Filer)
Form ARS
06/07/2024
5:26 AM
Haemonetics (Filer)
Form DEF 14A
05/29/2024
4:42 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:44 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:27 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:31 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:35 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:38 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
10:06 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
9:24 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
5:03 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
4:49 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:52 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:55 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:58 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
5:01 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
5:05 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:41 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:46 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:38 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
10:13 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
10:24 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
9:45 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
5:16 AM
Haemonetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/17/2024
4:11 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:52 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:55 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
11:15 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
9:07 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
11:57 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
11:12 AM
Basil Michelle L (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
11:15 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
5:04 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:21 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
1:08 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:18 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
7:01 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Young billionaire opens the door for millions of Americans (Ad)

You can now profit from a catalog of 11 inventions that will likely make their way into millions of U.S. households in the months and years to come. And you can do this whether you’re rich or poor… There are no special income requirements.

Anyone can do this.
03/13/2024
3:44 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
5:10 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
2:28 PM
Haemonetics (Subject)
Neuberger Berman Group LLC (Filed by)
Form SC 13G/A
02/09/2024
4:49 PM
Capital Research Global Investors (Filed by)
Haemonetics (Subject)
Form SC 13G/A
02/08/2024
9:21 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/08/2024
5:05 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
5:06 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/12/2023
5:09 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
3:36 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
5:19 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
5:16 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2023
3:23 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2023
3:27 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
5:10 AM
Haemonetics (Filer)
Form 8-K/A
10/10/2023
5:06 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:16 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:19 PM
Haemonetics (Issuer)
Strong Stewart W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:20 PM
Haemonetics (Issuer)
Lingamneni Anila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
11:19 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
12:22 PM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:23 PM
Dockendorff Charles J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
1:23 PM
Dockendorff Charles J (Reporting)
Haemonetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
5:09 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
5:01 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
3:17 PM
Haemonetics (Issuer)
Llorens Josep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
11:55 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:HAE) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners